nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexfenfluramine—CYP2A6—Methoxsalen—hematologic cancer	0.0605	0.065	CbGbCtD
Dexfenfluramine—CYP1A2—Anagrelide—hematologic cancer	0.0517	0.0555	CbGbCtD
Dexfenfluramine—CYP2A6—Ifosfamide—hematologic cancer	0.0441	0.0474	CbGbCtD
Dexfenfluramine—CYP2E1—Thalidomide—hematologic cancer	0.0331	0.0355	CbGbCtD
Dexfenfluramine—CYP2C9—Bexarotene—hematologic cancer	0.0323	0.0347	CbGbCtD
Dexfenfluramine—CYP2A6—Prednisolone—hematologic cancer	0.0294	0.0316	CbGbCtD
Dexfenfluramine—CYP2E1—Dacarbazine—hematologic cancer	0.0284	0.0306	CbGbCtD
Dexfenfluramine—CYP2D6—Lomustine—hematologic cancer	0.0274	0.0295	CbGbCtD
Dexfenfluramine—CYP1A2—Carmustine—hematologic cancer	0.0271	0.0292	CbGbCtD
Dexfenfluramine—CYP2C9—Idarubicin—hematologic cancer	0.0267	0.0287	CbGbCtD
Dexfenfluramine—CYP2D6—Idarubicin—hematologic cancer	0.0245	0.0263	CbGbCtD
Dexfenfluramine—CYP2C19—Bortezomib—hematologic cancer	0.0238	0.0256	CbGbCtD
Dexfenfluramine—CYP1A2—Methoxsalen—hematologic cancer	0.0231	0.0248	CbGbCtD
Dexfenfluramine—CYP2E1—Mitoxantrone—hematologic cancer	0.0221	0.0237	CbGbCtD
Dexfenfluramine—CYP1A2—Bortezomib—hematologic cancer	0.022	0.0236	CbGbCtD
Dexfenfluramine—CYP1A2—Daunorubicin—hematologic cancer	0.021	0.0226	CbGbCtD
Dexfenfluramine—CYP2D6—Hydroxyurea—hematologic cancer	0.0208	0.0223	CbGbCtD
Dexfenfluramine—CYP2C19—Thalidomide—hematologic cancer	0.0207	0.0223	CbGbCtD
Dexfenfluramine—CYP1A2—Alitretinoin—hematologic cancer	0.0206	0.0221	CbGbCtD
Dexfenfluramine—CYP2C9—Bortezomib—hematologic cancer	0.0198	0.0213	CbGbCtD
Dexfenfluramine—CYP2C19—Teniposide—hematologic cancer	0.0198	0.0212	CbGbCtD
Dexfenfluramine—CYP1A2—Thalidomide—hematologic cancer	0.0191	0.0206	CbGbCtD
Dexfenfluramine—CYP2C19—Ifosfamide—hematologic cancer	0.0183	0.0196	CbGbCtD
Dexfenfluramine—CYP2D6—Bortezomib—hematologic cancer	0.0181	0.0194	CbGbCtD
Dexfenfluramine—CYP2C19—Imatinib—hematologic cancer	0.0174	0.0187	CbGbCtD
Dexfenfluramine—CYP2A6—Dexamethasone—hematologic cancer	0.0173	0.0186	CbGbCtD
Dexfenfluramine—CYP2C9—Thalidomide—hematologic cancer	0.0172	0.0185	CbGbCtD
Dexfenfluramine—CYP1A2—Dacarbazine—hematologic cancer	0.0164	0.0177	CbGbCtD
Dexfenfluramine—CYP2C9—Teniposide—hematologic cancer	0.0164	0.0177	CbGbCtD
Dexfenfluramine—CYP1A2—Imatinib—hematologic cancer	0.0161	0.0173	CbGbCtD
Dexfenfluramine—CYP2C9—Ifosfamide—hematologic cancer	0.0152	0.0163	CbGbCtD
Dexfenfluramine—CYP2C9—Imatinib—hematologic cancer	0.0145	0.0156	CbGbCtD
Dexfenfluramine—CYP2E1—Etoposide—hematologic cancer	0.0139	0.015	CbGbCtD
Dexfenfluramine—CYP2D6—Imatinib—hematologic cancer	0.0133	0.0142	CbGbCtD
Dexfenfluramine—CYP2C9—Nilotinib—hematologic cancer	0.0132	0.0142	CbGbCtD
Dexfenfluramine—CYP1A2—Dasatinib—hematologic cancer	0.0129	0.0139	CbGbCtD
Dexfenfluramine—CYP2D6—Nilotinib—hematologic cancer	0.012	0.0129	CbGbCtD
Dexfenfluramine—CYP2D6—Vinorelbine—hematologic cancer	0.0119	0.0128	CbGbCtD
Dexfenfluramine—CYP2C19—Prednisone—hematologic cancer	0.0115	0.0123	CbGbCtD
Dexfenfluramine—CYP2E1—Dexamethasone—hematologic cancer	0.0114	0.0123	CbGbCtD
Dexfenfluramine—CYP1A2—Etoposide—hematologic cancer	0.00805	0.00865	CbGbCtD
Dexfenfluramine—CYP2C9—Cisplatin—hematologic cancer	0.00738	0.00793	CbGbCtD
Dexfenfluramine—CYP2D6—Vinblastine—hematologic cancer	0.00736	0.00791	CbGbCtD
Dexfenfluramine—CYP2C19—Dexamethasone—hematologic cancer	0.00717	0.0077	CbGbCtD
Dexfenfluramine—CYP2C9—Dexamethasone—hematologic cancer	0.00596	0.00641	CbGbCtD
Dexfenfluramine—CYP2D6—Dexamethasone—hematologic cancer	0.00545	0.00586	CbGbCtD
Dexfenfluramine—CYP2D6—Doxorubicin—hematologic cancer	0.00452	0.00486	CbGbCtD
Dexfenfluramine—CYP2C9—Metabolism—GSTT1—hematologic cancer	8.44e-06	0.000122	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PDGFRA—hematologic cancer	8.44e-06	0.000122	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—JAK1—hematologic cancer	8.41e-06	0.000121	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PRKCG—hematologic cancer	8.41e-06	0.000121	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—NFKBIA—hematologic cancer	8.37e-06	0.000121	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—BAD—hematologic cancer	8.37e-06	0.000121	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—SDC1—hematologic cancer	8.32e-06	0.00012	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GSTP1—hematologic cancer	8.32e-06	0.00012	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.31e-06	0.00012	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ALOX5—hematologic cancer	8.29e-06	0.00012	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—NOTCH1—hematologic cancer	8.29e-06	0.00012	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—SDC1—hematologic cancer	8.25e-06	0.000119	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.16e-06	0.000118	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CD80—hematologic cancer	8.12e-06	0.000117	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CG—hematologic cancer	8.11e-06	0.000117	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—KIT—hematologic cancer	8.11e-06	0.000117	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—NRAS—hematologic cancer	8.11e-06	0.000117	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NUP98—hematologic cancer	8.03e-06	0.000116	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PTPN11—hematologic cancer	7.97e-06	0.000115	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.88e-06	0.000114	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ABCB1—hematologic cancer	7.87e-06	0.000114	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL2RA—hematologic cancer	7.85e-06	0.000113	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NCOA3—hematologic cancer	7.8e-06	0.000113	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ADCY7—hematologic cancer	7.8e-06	0.000113	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—IL2—hematologic cancer	7.79e-06	0.000113	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.78e-06	0.000112	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—MAPK3—hematologic cancer	7.77e-06	0.000112	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TERT—hematologic cancer	7.76e-06	0.000112	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NUP214—hematologic cancer	7.74e-06	0.000112	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CREB1—hematologic cancer	7.72e-06	0.000112	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CD44—hematologic cancer	7.69e-06	0.000111	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—NQO1—hematologic cancer	7.69e-06	0.000111	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.66e-06	0.000111	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—NCOR1—hematologic cancer	7.64e-06	0.00011	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GSTM1—hematologic cancer	7.64e-06	0.00011	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—BRAF—hematologic cancer	7.62e-06	0.00011	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—MTR—hematologic cancer	7.58e-06	0.00011	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ABCG2—hematologic cancer	7.58e-06	0.00011	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PDGFB—hematologic cancer	7.58e-06	0.000109	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCL2—hematologic cancer	7.55e-06	0.000109	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.53e-06	0.000109	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL6R—hematologic cancer	7.53e-06	0.000109	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CREBBP—hematologic cancer	7.52e-06	0.000109	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.44e-06	0.000108	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ENO2—hematologic cancer	7.44e-06	0.000107	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TSC2—hematologic cancer	7.41e-06	0.000107	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYCS—hematologic cancer	7.28e-06	0.000105	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	7.23e-06	0.000105	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTT1—hematologic cancer	7.21e-06	0.000104	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CG—hematologic cancer	7.18e-06	0.000104	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MAP2K1—hematologic cancer	7.18e-06	0.000104	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CD—hematologic cancer	7.13e-06	0.000103	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—FGFR3—hematologic cancer	7.13e-06	0.000103	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.1e-06	0.000103	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CD44—hematologic cancer	7.08e-06	0.000102	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—NQO1—hematologic cancer	7.08e-06	0.000102	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—PIK3CA—hematologic cancer	7.06e-06	0.000102	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MAPK14—hematologic cancer	7.05e-06	0.000102	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—SDC1—hematologic cancer	7.05e-06	0.000102	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—NQO1—hematologic cancer	7.02e-06	0.000101	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CD44—hematologic cancer	7.02e-06	0.000101	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—KRAS—hematologic cancer	6.98e-06	0.000101	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ESR1—hematologic cancer	6.92e-06	0.0001	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.87e-06	9.93e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—FN1—hematologic cancer	6.84e-06	9.88e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—FGF2—hematologic cancer	6.83e-06	9.86e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—MTHFR—hematologic cancer	6.76e-06	9.76e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—BAD—hematologic cancer	6.75e-06	9.76e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NFKBIA—hematologic cancer	6.75e-06	9.76e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.74e-06	9.73e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3R1—hematologic cancer	6.73e-06	9.73e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYCS—hematologic cancer	6.7e-06	9.68e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NOTCH1—hematologic cancer	6.69e-06	9.67e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CREBBP—hematologic cancer	6.66e-06	9.62e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	6.65e-06	9.61e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.65e-06	9.61e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYCS—hematologic cancer	6.64e-06	9.59e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	6.6e-06	9.53e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CD80—hematologic cancer	6.55e-06	9.47e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—JAK2—hematologic cancer	6.54e-06	9.45e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—KIT—hematologic cancer	6.54e-06	9.45e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CG—hematologic cancer	6.54e-06	9.45e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—NRAS—hematologic cancer	6.54e-06	9.45e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.51e-06	9.41e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PTPN11—hematologic cancer	6.43e-06	9.29e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTP1—hematologic cancer	6.42e-06	9.27e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—PIK3CA—hematologic cancer	6.41e-06	9.26e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MDM2—hematologic cancer	6.39e-06	9.23e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.36e-06	9.19e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CD—hematologic cancer	6.31e-06	9.12e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—MAPK3—hematologic cancer	6.27e-06	9.05e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ALB—hematologic cancer	6.23e-06	9.01e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CREB1—hematologic cancer	6.23e-06	9e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MTOR—hematologic cancer	6.21e-06	8.98e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CB—hematologic cancer	6.21e-06	8.98e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.21e-06	8.97e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—BRAF—hematologic cancer	6.15e-06	8.88e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCL2—hematologic cancer	6.09e-06	8.8e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ABCB1—hematologic cancer	6.07e-06	8.78e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL6R—hematologic cancer	6.07e-06	8.78e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CREBBP—hematologic cancer	6.07e-06	8.76e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CD44—hematologic cancer	6e-06	8.66e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NQO1—hematologic cancer	6e-06	8.66e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3R1—hematologic cancer	5.96e-06	8.61e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.94e-06	8.58e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HRAS—hematologic cancer	5.93e-06	8.57e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTP1—hematologic cancer	5.9e-06	8.53e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—NCOR1—hematologic cancer	5.9e-06	8.52e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTM1—hematologic cancer	5.9e-06	8.52e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.87e-06	8.48e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTP1—hematologic cancer	5.85e-06	8.45e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CDKN1B—hematologic cancer	5.83e-06	8.42e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MAP2K1—hematologic cancer	5.79e-06	8.36e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—AKT1—hematologic cancer	5.77e-06	8.33e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CD—hematologic cancer	5.75e-06	8.31e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CASP3—hematologic cancer	5.71e-06	8.26e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL2—hematologic cancer	5.71e-06	8.24e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—PIK3CA—hematologic cancer	5.7e-06	8.23e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—IL6—hematologic cancer	5.68e-06	8.2e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CG—hematologic cancer	5.68e-06	8.2e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYCS—hematologic cancer	5.67e-06	8.2e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.66e-06	8.18e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	5.64e-06	8.14e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—KRAS—hematologic cancer	5.63e-06	8.13e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ABCB1—hematologic cancer	5.59e-06	8.07e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCND1—hematologic cancer	5.56e-06	8.04e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—JUN—hematologic cancer	5.55e-06	8.02e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ABCB1—hematologic cancer	5.54e-06	8e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—FGF2—hematologic cancer	5.51e-06	7.96e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CB—hematologic cancer	5.5e-06	7.95e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3R1—hematologic cancer	5.43e-06	7.85e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—NCOR1—hematologic cancer	5.42e-06	7.84e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTM1—hematologic cancer	5.42e-06	7.84e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CDKN1A—hematologic cancer	5.38e-06	7.77e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTM1—hematologic cancer	5.38e-06	7.77e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—NCOR1—hematologic cancer	5.38e-06	7.77e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PTEN—hematologic cancer	5.37e-06	7.76e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—JAK2—hematologic cancer	5.28e-06	7.63e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CREBBP—hematologic cancer	5.26e-06	7.6e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MAPK8—hematologic cancer	5.25e-06	7.59e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—AKT1—hematologic cancer	5.24e-06	7.57e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—MTHFR—hematologic cancer	5.21e-06	7.53e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PIK3CA—hematologic cancer	5.17e-06	7.47e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MDM2—hematologic cancer	5.15e-06	7.44e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—EP300—hematologic cancer	5.12e-06	7.4e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.07e-06	7.33e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MTOR—hematologic cancer	5.01e-06	7.24e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CB—hematologic cancer	5.01e-06	7.24e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTP1—hematologic cancer	5e-06	7.22e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CD—hematologic cancer	4.99e-06	7.21e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SRC—hematologic cancer	4.98e-06	7.19e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ALB—hematologic cancer	4.93e-06	7.12e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—VEGFA—hematologic cancer	4.85e-06	7.01e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.84e-06	6.99e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—STAT3—hematologic cancer	4.8e-06	6.94e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—MTHFR—hematologic cancer	4.79e-06	6.93e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—NRAS—hematologic cancer	4.79e-06	6.92e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HRAS—hematologic cancer	4.79e-06	6.91e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PTEN—hematologic cancer	4.76e-06	6.87e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—MTHFR—hematologic cancer	4.75e-06	6.87e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ABCB1—hematologic cancer	4.73e-06	6.84e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3R1—hematologic cancer	4.71e-06	6.81e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CDKN1B—hematologic cancer	4.7e-06	6.8e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—AKT1—hematologic cancer	4.65e-06	6.72e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CASP3—hematologic cancer	4.61e-06	6.66e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL2—hematologic cancer	4.6e-06	6.65e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTM1—hematologic cancer	4.6e-06	6.64e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NCOR1—hematologic cancer	4.6e-06	6.64e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.59e-06	6.64e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MAPK3—hematologic cancer	4.59e-06	6.63e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—IL6—hematologic cancer	4.58e-06	6.62e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—EP300—hematologic cancer	4.54e-06	6.55e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCND1—hematologic cancer	4.49e-06	6.48e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—JUN—hematologic cancer	4.48e-06	6.47e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MYC—hematologic cancer	4.46e-06	6.45e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TGFB1—hematologic cancer	4.45e-06	6.43e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	4.38e-06	6.33e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CB—hematologic cancer	4.35e-06	6.28e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CDKN1A—hematologic cancer	4.34e-06	6.27e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PTEN—hematologic cancer	4.33e-06	6.26e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MAPK8—hematologic cancer	4.24e-06	6.12e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—AKT1—hematologic cancer	4.23e-06	6.11e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.19e-06	6.05e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—EP300—hematologic cancer	4.13e-06	5.97e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—KRAS—hematologic cancer	4.12e-06	5.96e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—MTHFR—hematologic cancer	4.06e-06	5.87e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CREBBP—hematologic cancer	4.06e-06	5.87e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	4.03e-06	5.82e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SRC—hematologic cancer	4.02e-06	5.8e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	3.99e-06	5.77e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—VEGFA—hematologic cancer	3.91e-06	5.65e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—STAT3—hematologic cancer	3.87e-06	5.6e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NRAS—hematologic cancer	3.86e-06	5.58e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	3.85e-06	5.56e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ALB—hematologic cancer	3.8e-06	5.49e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CA—hematologic cancer	3.79e-06	5.47e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PTEN—hematologic cancer	3.76e-06	5.43e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.73e-06	5.4e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CREBBP—hematologic cancer	3.7e-06	5.35e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MAPK3—hematologic cancer	3.7e-06	5.35e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TP53—hematologic cancer	3.66e-06	5.29e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	3.64e-06	5.25e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MYC—hematologic cancer	3.6e-06	5.2e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	3.59e-06	5.19e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—EP300—hematologic cancer	3.58e-06	5.18e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.58e-06	5.17e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	3.54e-06	5.12e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	3.51e-06	5.07e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HRAS—hematologic cancer	3.5e-06	5.06e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ALB—hematologic cancer	3.5e-06	5.05e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ALB—hematologic cancer	3.47e-06	5.01e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	3.41e-06	4.93e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	3.36e-06	4.85e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CA—hematologic cancer	3.35e-06	4.85e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL6—hematologic cancer	3.35e-06	4.85e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	3.34e-06	4.83e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—KRAS—hematologic cancer	3.33e-06	4.81e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	3.31e-06	4.79e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CREBBP—hematologic cancer	3.16e-06	4.57e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AKT1—hematologic cancer	3.09e-06	4.47e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	3.09e-06	4.46e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.06e-06	4.42e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	3.06e-06	4.42e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	3e-06	4.33e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ALB—hematologic cancer	2.96e-06	4.28e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TP53—hematologic cancer	2.96e-06	4.27e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PTEN—hematologic cancer	2.9e-06	4.19e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.83e-06	4.09e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HRAS—hematologic cancer	2.83e-06	4.08e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—EP300—hematologic cancer	2.77e-06	4e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—AKT1—hematologic cancer	2.74e-06	3.96e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL6—hematologic cancer	2.71e-06	3.91e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PTEN—hematologic cancer	2.67e-06	3.85e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	2.65e-06	3.83e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PTEN—hematologic cancer	2.64e-06	3.82e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.61e-06	3.78e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—EP300—hematologic cancer	2.54e-06	3.67e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—EP300—hematologic cancer	2.52e-06	3.64e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AKT1—hematologic cancer	2.5e-06	3.61e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PTEN—hematologic cancer	2.26e-06	3.26e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—AKT1—hematologic cancer	2.17e-06	3.13e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—EP300—hematologic cancer	2.15e-06	3.11e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	2.05e-06	2.96e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.88e-06	2.72e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.87e-06	2.69e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—AKT1—hematologic cancer	1.67e-06	2.41e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.59e-06	2.3e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.54e-06	2.22e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—AKT1—hematologic cancer	1.52e-06	2.2e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—AKT1—hematologic cancer	1.3e-06	1.88e-05	CbGpPWpGaD
